Want to see PBLS full AI Analyst Report?
Parabilis Medicines, Inc. (PBLS) Ownership - Who Owns Parabilis Medicines, Inc.?
Parabilis Medicines, Inc. (PBLS) Ownership Overview
- 26.02% Insiders
- 5.43% Mutual Funds
- 0.02% Other Institutional Investors
- 4.25% ETFs
- 64.28% Public Companies and Individual Investors
The ownership structure of Parabilis Medicines, Inc. (PBLS) stock is a mix of institutional, retail, and individual investors. Approximately 9.69% of the company’s stock is owned by Institutional Investors, 26.02% is owned by Insiders, and 64.28% is owned by Public Companies and Individual Investors.
The ownership structure of Parabilis Medicines, Inc. (PBLS) stock is a mix of institutional, retail, and individual investors. Approximately 9.69% of the company’s stock is owned by Institutional Investors, 26.02% is owned by Insiders, and 64.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jul 21, 2026 | Ra Capital Management, Llc | $6,919,551 | |
| Jun 28, 2026 | Guy Levy | $4,996,624 | |
| Jun 28, 2026 | Guy Levy | $10,000,000 | |
| Jun 15, 2026 | Alan Sebulsky | $473,383 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Driehaus Capital Management Llc | $2,737,000 | |
| Jun 30, 2026 | Farallon Capital Management, L.l.c. | $64,817,634 | |
| Jun 30, 2026 | Deerfield Management Company, Lp | $51,474,868 | |
| Jun 30, 2026 | Baker Bros Advisors Lp | $13,685,000 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ra Capital Management, Llc | 29,177,964 | Insider | 23.93% | 826,319,940 |
| Peter Kolchinsky | 28,933,371 | Institution | 23.73% | 819,393,067 |
| Vanguard | 3,102,982 | Institution | 2.54% | 87,876,450 |
| Vanguard Index Funds | 2,424,217 | Institution | 1.99% | 68,653,825 |
| Andrew J.M. Spokes | 2,368,200 | Institution | 1.94% | 67,067,424 |
| James E. Flynn | 1,880,704 | Insider | 1.54% | 53,261,537 |
| James E. Flynn | 1,880,704 | Institution | 1.54% | 53,261,537 |
| Ishares | 1,437,889 | Institution | 1.18% | 40,721,016 |
| Fidelity Mt. Vernon Street Trust | 703,700 | Institution | 0.58% | 19,928,784 |
| Guy Levy | 527,070 | Insider | 0.43% | 14,926,622 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,424,217 | Institution | 1.99% | 68,653,825 |
| Fidelity Mt. Vernon Street Trust | 703,700 | Institution | 0.58% | 19,928,784 |
| T. Rowe Price Health Sciences Fund, Inc. | 486,669 | Institution | 0.40% | 13,782,466 |
| Jpmorgan Trust Ii | 480,209 | Institution | 0.39% | 13,599,519 |
| Fidelity Select Portfolios | 436,412 | Institution | 0.36% | 12,359,188 |
| Ab Cap Fund, Inc. | 329,809 | Institution | 0.27% | 9,340,191 |
| Janus Investment Fund | 313,255 | Institution | 0.26% | 8,871,382 |
| Mfs Series Trust I | 271,771 | Institution | 0.22% | 7,696,555 |
| Franklin Strategic Series | 249,421 | Institution | 0.20% | 7,063,603 |
| Federated Hermes Equity Funds | 243,000 | Institution | 0.20% | 6,881,760 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 1,121,000 | Institution | 0.92% | 36,197,090 |
| iShares, IWM ETF | 1,003,641 | Institution | 0.82% | 28,804,497 |
| Vanguard, VB ETF | 792,723 | Institution | 0.65% | 25,597,026 |
| Vanguard, VBR ETF | 515,681 | Institution | 0.42% | 16,651,339 |
| Vanguard, VXF ETF | 399,284 | Institution | 0.33% | 12,892,880 |
| Vanguard, VTWO ETF | 230,166 | Institution | 0.19% | 7,432,060 |
| iShares, IWO ETF | 225,232 | Institution | 0.18% | 6,378,570 |
| Schwab, SCHA ETF | 187,133 | Institution | 0.15% | 5,370,717 |
| iShares, IWN ETF | 148,312 | Institution | 0.12% | 4,256,554 |
| Fidelity, FESM ETF | 71,022 | Institution | 0.06% | 2,038,331 |
FAQ
Who Owns Parabilis Medicines, Inc. (PBLS)?
According to the latest TipRanks data, approximately 9.69% of the company's stock is held by institutional investors, 26.02% is held by insiders, and 64.28% is held by public companies and individual investors.
What percentage of Parabilis Medicines, Inc. (PBLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.69% of Parabilis Medicines, Inc. (PBLS) stock is held by institutional investors: 5.43% by mutual funds, 4.25% by ETFs and 0.02% by other institutional investors.
What percentage of Parabilis Medicines, Inc. (PBLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.28% of Parabilis Medicines, Inc. (PBLS) stock is held by public companies and individual investors.
Who owns the most shares of Parabilis Medicines, Inc. (PBLS)?
Ra Capital Management, Llc owns the most shares of Parabilis Medicines, Inc. (PBLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
